GlassScriptPhysician profile
Saroja S Jayakar
NPI 1144259995
$577.22
in general payments reported to CMS, 2019-2025
16 companies · $50.65 in 2025
The $50.65 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.23 · 2020: $92.93 · 2021: $54.59 · 2022: $14.80 · 2023: $61.47 · 2024: $289 · 2025: $50.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.68 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $138.31 | 2024 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $115.56 | 2021-2024 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.73 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $42.44 | 2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $29.95 | 2023-2024 | Airsupra, Breztri |
| Lilly USA, LLC | $28.62 | 2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $28.26 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $21.20 | 2021 | |
| Axsome Therapeutics, INC. | $19.41 | 2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $16.93 | 2025 | |
| Alnylam Pharmaceuticals INC. | $15.99 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $14.77 | 2024 | Rhythm Express |
| Pfizer INC. | $14.61 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.23 | 2019 | |
| Vanda Pharmaceuticals INC. | $13.45 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saroja Jayakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.